Overview

Ritanserin in Treatment of Cocaine Dependence - 1

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Ritanserin